Related Experiment Video
Updated: Jan 13, 2026

Evaluating the Effect of SASP Factors on the Proliferation of Cancer Cells Using a Comparative Analysis of Three Distinct Methodologies
Published on: September 19, 2025
Impact of pharmacist-led interventions on oncology drug therapy outcomes: a systematic review and meta-analysis
Hong-Wei Xiang1,2, Yong-Ye Shen3, Jing-Xin Wang4
1Department of Pharmacy, Xiyuan Hospital, China Academy of Chinese Medical Sciences, No. 1 Xiyuan Road, Haidian District, Beijing 100091, China.
Objectives:
To systematically evaluate the management effectiveness of pharmacist involvement in clinical oncology drug therapy and elucidate the unique value of pharmacists in cancer treatment.
Methods:
We conducted systematic searches in PubMed, Embase, and Web of Science to identify randomized controlled trials (RCTs) and non-randomized intervention studies (NRSIs), evaluating the impact of pharmacist interventions on clinical outcomes in cancer patients. Following rigorous evaluation of titles/abstracts and full texts, literature screening, data extraction, and quality assessment using validated assessment scales were performed. The meta-analyses were conducted utilizing the RevMan 5.4 software.
Key Findings:
The analysis encompassed 20 RCTs and 6 NRSIs with a total of 3859 participants. Meta-analysis demonstrated statistically significant reductions in the pharmacist interventions group for adverse reaction incidence rates, particularly nausea (OR = 0.55, 95% CI (0.44, 0.70), P < .00001), and vomiting [OR = 0.45, 95% CI (0.28, 0.73), P = .001]. The pharmacist intervention group had a higher pain relief rate [OR = 1.99, 95% CI (1.06, 3.76), P = .03], medication compliance [OR = 4.11, 95% CI (2.40, 7.02), P < .00001], and quality of life (QoL) indicators.
Conclusions:
Current evidence confirms that pharmacist-led Interventions (including pharmacovigilance, medication counseling, pain management, therapeutic education, and medication reconciliation) effectively reduce adverse events and pain burden in cancer patients while enhancing treatment adherence and QoL. These findings substantiate the critical role of pharmacists as integral members of multidisciplinary teams in optimizing oncology therapeutic outcomes.
More Related Videos
09:19Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Survival Analysis
Treatment Resistant Cancers
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...